BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 31814880)

  • 1. Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies.
    Rodríguez ML; Pérez S; Mena-Mollá S; Desco MC; Ortega ÁL
    Oxid Med Cell Longev; 2019; 2019():4940825. PubMed ID: 31814880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for and managing diabetic retinopathy: current approaches.
    Bloomgarden ZT
    Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S8-14. PubMed ID: 17720893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic retinopathy: current management and experimental therapeutic targets.
    Ali TK; El-Remessy AB
    Pharmacotherapy; 2009 Feb; 29(2):182-92. PubMed ID: 19170588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the treatment of diabetic retinopathy.
    Yam JC; Kwok AK
    Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy.
    Chalke SD; Kale PP
    Curr Drug Targets; 2021; 22(16):1810-1824. PubMed ID: 33745432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiopathy and the eye].
    Rencová E
    Vnitr Lek; 2010 Apr; 56(4):333-9. PubMed ID: 20465107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic retinopathy: pathogenesis and therapeutic implications].
    Pelikánová T
    Vnitr Lek; 2016; 62(7-8):620-8. PubMed ID: 27627088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic retinopathy: current concepts of evaluation and treatment.
    Frank RN
    Clin Endocrinol Metab; 1986 Nov; 15(4):933-69. PubMed ID: 3536206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
    Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
    Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
    Narayanan SP; Shosha E; D Palani C
    Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal approach to diabetic macular edema.
    Au A; Singh RP
    J Diabetes Complications; 2016 Apr; 30(3):545-53. PubMed ID: 26853628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.
    Prescrire Int; 2010 Feb; 19(105):35-8. PubMed ID: 20455344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.
    Mohamed QA; Fletcher EC; Buckle M
    BMJ Clin Evid; 2016 Mar; 2016():. PubMed ID: 27031563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Pharmacologic Therapies for Diabetic Retinopathy.
    Villegas VM; Schwartz SG
    Curr Pharm Des; 2018; 24(41):4903-4910. PubMed ID: 30706803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic possibilities for diabetic macular oedema].
    Wiemer NG; Polak BC; Veckeneer MA
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2183-7. PubMed ID: 17061428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and investigational drugs for the treatment of diabetic retinopathy.
    Tolentino MS; Tolentino AJ; Tolentino MJ
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1011-22. PubMed ID: 27367620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diabetic retinopathy: a systematic review.
    Mohamed Q; Gillies MC; Wong TY
    JAMA; 2007 Aug; 298(8):902-16. PubMed ID: 17712074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Liou GI; Caldwell RW
    Curr Drug Targets; 2005 Jun; 6(4):511-24. PubMed ID: 16026270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments.
    Heng LZ; Comyn O; Peto T; Tadros C; Ng E; Sivaprasad S; Hykin PG
    Diabet Med; 2013 Jun; 30(6):640-50. PubMed ID: 23205608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.